1975 - 1979 University of San Carlos, Cebu City, Phils., BS Biology
1979 - 1983 Cebu Institute of Medicine, Cebu City Phils., M.D.
1983 - 1984 Chinese General Hospital, Manila, Phils., Post-graduate Internship
1985 - 1986 Philippine General Hospital, Manila, Phils., Internal Medicine Fellowship
1986 - 1989 Wayne State Univ - Detroit Med Center, Detroit, MI, Internal Medicine Residency
1989 - 1992 Indiana Univ Med Center, Indianapolis, IN, Hematology-Oncology Fellowship
1992 - 1993 Indiana Univ Med Center, Indianapolis, IN, Bone Marrow Transplant Fellowship
Diplomate, American Board of Internal Medicine, 1989
Diplomate, ABIM Medical Oncology Subspecialty, 1991
Diplomate, ABIM Hematology Subspecialty, 1992
Cytomegalovirus infections and their prevention in bone marrow transplant recipients
Minimal Residual Disease monitoring and treatment
Electronic mailing List Discussion Group BMT-Dr for BMT physicians and scientists (Coowner)
Virtual Hematopathology: Clinical cases for diagnosis (WEB site author)
Mandanas RA, Einhorn LH, Wheeler B, Ansari R, Lutz T, Miller M. Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer: a Hoosier Oncology Group (HOG) phase II trial. Amer J Clin Oncol 16:519-521, 1993.
Mandanas RA, Leibowitz D, Gharehbaghi K, Miyazawa K, Jayaram N, Boswell HS. Role of p21RAS in p210 BCR-ABL transformation of murine myeloid cell lines. Blood 82:1838-1847, 1993.
Mandanas RA, Saez RA, Selby GB, Confer DL. Cytomegalovirus Surveillance and Preventionin Allogeneic Transplants: Examination of a Preemptive Plan of Ganciclovir Therapy. Accepted for Publication, Am J Hematol, Sept. 1995.